Skinny, Inc. Part 2: The big business of Ozempic

The Decibel by The Globe and Mail

Aug 14, 202600:32:58News & Politics

GLP-1 medications to treat diabetes, obesity and several other illnesses have exploded in popularity since Ozempic was approved for use in Canada back in 2018. Ozempic and Wegovy, the GLP-1s which contain semaglutide, ar...

Related Episodes

Continue listening to more episodes from The Decibel.

The trade war has created a boom for lobbyists

Sep 11, 2026 - 00:21:10

Personal connections have always mattered when it comes to political lobbying, but as the trade war ramps...

What the current bond market turmoil says about the economy

Sep 10, 2026 - 00:22:21

Scary bond market headlines – warnings of an impending financial crisis – have been in the news for weeks...

The trade war is heating up. So is foreign investment in Canada

Sep 9, 2026 - 00:18:19

With Canada’s countertariffs coming into effect on roughly $28-billion worth of U.S. goods on Tuesday, th...

Violence against teachers is surging

Sep 8, 2026 - 00:26:45

A growing and worrying trend is happening in Canadian schools – student violence against teachers is on t...

Canadian professors on how AI is changing education

Sep 4, 2026 - 00:28:22

A big issue hangs over university students and professors, and that’s artificial intelligence. There are...

A pediatric emergency physician on the risks of e-scooters

Sep 3, 2026 - 00:21:00

The popularity of e-scooters on Canadian roads has exploded in recent years. But new data from health off...

What’s behind the implosion of the B.C. Conservatives

Sep 2, 2026 - 00:25:52

It’s been a turbulent time for the official opposition of the British Columbia provincial legislature, th...

How small businesses are handling the trade war

Sep 1, 2026 - 00:18:28

The 50-per-cent tariffs from the U.S. that came into effect on Aug. 22 are hitting a long list of goods —...